Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use APONVIE® safely and effectively. See full prescribing information for APONVIE. APONVIE® (aprepitant) injectable emulsion, for intravenous use Initial U.S. Approval: 2003
Medication labelWhy this: Advisory · dailymed-prescription
APONVIE is indicated for the prevention of postoperative nausea and vomiting (PONV) in adults. Limitations of Use APONVIE has not been studied for the treatment of established nausea and vomiting.
- generic_name
- aprepitant
- product_names
- APREPITANT
- ndc
- 47426-401, 47426-401-01, 47426-401-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en